Michel Chartrain

2.4k citations

64 papers · 1.8k indexed · h-index 23

Impact in

Biotechnology top 5%
Molecular Biology top 10%
- Enzyme Catalysis and Immobilization
- Microbial Metabolic Engineering and Bioproduction
- Viral Infectious Diseases and Gene Expression in Insects
- Protein purification and stability

Papers in ⓘ

Molecular Biology 54
- Enzyme Catalysis and Immobilization 29
- Microbial Metabolic Engineering and Bioproduction 25
- Steroid Chemistry and Biochemistry 15
- Viral Infectious Diseases and Gene Expression in Insects 10
Biomedical Engineering 16
- Innovative Microfluidic and Catalytic Techniques Innovation 8
- Biofuel production and bioconversion 6

Co-authors: J. G. Zeikus (5 shared papers)Barry C. Buckland (9 shared papers)Randolph Greasham (19 shared papers)David K. Robinson (7 shared papers)Kristala Jones Prather (1 shared paper)Jason C. Murphy (1 shared paper)Sangeetha L. Sagar (1 shared paper)Jürgen Thiele (1 shared paper)
Journals: Journal of Industrial Microbiology & Biotechnology (9 papers)Enzyme and Microbial Technology (6 papers)Applied and Environmental Microbiology (4 papers)Journal of Molecular Catalysis B Enzymatic (3 papers)Biotechnology Progress (3 papers)
Partner nations: United States United Kingdom Australia

In The Last Decade

Michel Chartrain

62 papers receiving 1.7k citations

Peers

Countries citing papers authored by Michel Chartrain

Since Specialization

Citations

This map shows the geographic impact of Michel Chartrain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Chartrain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Chartrain more than expected).

Fields of papers citing papers by Michel Chartrain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Chartrain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Chartrain. The network helps show where Michel Chartrain may publish in the future.

Co-authors

The 25 scholars most cited alongside Michel Chartrain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michel Chartrain Line = papers co-authored together Michel Chartrain links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Pharmaceuticals from cultured algae Journal of Industrial Microbiology & Biotechnology ·Robert E. Schwartz, C. F. Hirsch, David F. Sesin, James E. Flor, Michel Chartrain, Robert E. Fromtling, Guy H. Harris, Michael J. Salvatore, Jerrold M. Liesch, Katherine Yudin	1990	237
2	Industrial scale production of plasmid DNA for vaccine and gene therapy: plasmid design, production, and purification Enzyme and Microbial Technology ·Kristala Jones Prather, Sangeetha L. Sagar, Jason C. Murphy, Michel Chartrain	2003	167
3	Control of Interspecies Electron Flow during Anaerobic Digestion: Role of Floc Formation in Syntrophic Methanogenesis Applied and Environmental Microbiology ·Jürgen Thiele, Michel Chartrain, J. G. Zeikus	1988	113
4	Metabolic engineering and directed evolution for the production of pharmaceuticals Current Opinion in Biotechnology ·Michel Chartrain, Peter M. Salmon, David K. Robinson, Barry C. Buckland	2000	85
5	Optimized Single-Step Affinity Purification with a Self-Cleaving Intein Applied to Human Acidic Fibroblast Growth Factor Biotechnology Progress ·David W. Wood, Victoria Derbyshire, Wentao Wu, Michel Chartrain, Marlene Belfort, Georges Belfort	2000	76
6	Microbial Ecophysiology of Whey Biomethanation: Characterization of Bacterial Trophic Populations and Prevalent Species in Continuous Culture Applied and Environmental Microbiology ·Michel Chartrain, J. G. Zeikus	1986	76
7	Microbial Conversion of Indene to Indandiol: A Key Intermediate in the Synthesis of CRIXIVAN Metabolic Engineering ·Barry C. Buckland, Stephen W. Drew, Neal Connors, Michel Chartrain, Chanyong Lee, Peter M. Salmon, K. Gbewonyo, Weichang Zhou, Pat Gailliot, Rahul Singhvi, R. Olewinski, Wenjun Sun, Jayanthi Reddy, Jinyou Zhang, Barbara A. Jackey, Colleen Taylor, Kent E. Göklen, Beth Junker, Randolph Greasham	1999	58
8	An Asymmetric Synthesis of L-694,458, a Human Leukocyte Elastase Inhibitor, via Novel Enzyme Resolution of β-Lactam Esters The Journal of Organic Chemistry ·Raymond J. Cvetovich, Michel Chartrain, Frederick W. Hartner, Christopher Roberge, Joseph S. Amato, Edward J. J. Grabowski	1996	58
9	Development and Production of Commercial Therapeutic Monoclonal Antibodies in Mammalian Cell Expression Systems: An Overview of the Current Upstream Technologies Current Pharmaceutical Biotechnology ·Michel Chartrain, Lily Chu	2008	56
10	Asymmetric bioreductions: application to the synthesis of pharmaceuticals Journal of Molecular Catalysis B Enzymatic ·Michel Chartrain, Randolph Greasham, Jeffrey C. Moore, Paul J. Reider, David K. Robinson, Barry C. Buckland	2001	55
11	Purification and characterization of a novel bioconverting lipase from Pseudomonas aeruginosa MB 5001 Enzyme and Microbial Technology ·Michel Chartrain, Lorraine E. Levitt Katz, C. Marcin, M. Thien, Sheri Smith, Ethan L. Fisher, Kent E. Göklen, Peter Salmon, T. Brix, Karen M. Price, R. Greasham	1993	54
12	Bioconversion of indene to cis (1S,2R) indandiol and trans (1R,2R) indandiol by Rhodococcus species Journal of Fermentation and Bioengineering ·Michel Chartrain, Barbara A. Jackey, Colleen Taylor, Vanessa Sandford, K. Gbewonyo, Leonard M. Lister, Lisa DiMichele, C. F. Hirsch, Brian K. Heimbuch, Carrie Maxwell, Deborah Pascoe, Barry C. Buckland, Randolph Greasham	1998	50
13	Development of a defined medium fermentation process for physostigmine production by Streptomyces griseofuscus Applied Microbiology and Biotechnology ·J. Zhang, Claudia Fernández Martín, M. A. Shifflet, Peter Salmon, T. Brix, R. Greasham, B. Buckland, Michel Chartrain	1996	41
14	Biocatalysis for Pharmaceuticals—Status and Prospects for a Key Technology Metabolic Engineering ·Barry C. Buckland, David K. Robinson, Michel Chartrain	2000	40
15	Microbial Ecophysiology of Whey Biomethanation: Intermediary Metabolism of Lactose Degradation in Continuous Culture Applied and Environmental Microbiology ·Michel Chartrain, J. G. Zeikus	1986	40
16	Chiral bio-resolution of racemic indene oxide by fungal epoxide hydrolases Journal of Fermentation and Bioengineering ·Jinyou Zhang, J. Rama Krishna Reddy, Christopher Roberge, Chris H. Senanayake, Randolph Greasham, Michel Chartrain	1995	35
17	Development of a Highly Productive and Scalable Plasmid DNA Production Platform Biotechnology Progress ·K. Listner, Laura Kizer Bentley, J. Okonkowski, C. Kistler, Richard Wnek, Amy Caparoni, Beth Junker, David K. Robinson, Peter Salmon, Michel Chartrain	2006	33
18	Asymmetric bioreduction of a β-tetralone to its corresponding (S)-alcohol by the yeast Trichosporon capitatum MY 1890 Journal of Fermentation and Bioengineering ·Jayanthi Reddy, David M. Tschaen, Yao‐Jun Shi, Victor Pecore, L. N. Katz, Randolph Greasham, Michel Chartrain	1996	29
19	Microbial Ecophysiology of Whey Biomethanation: Comparison of Carbon Transformation Parameters, Species Composition, and Starter Culture Performance in Continuous Culture Applied and Environmental Microbiology ·Michel Chartrain, L. Bhatnagar, J. G. Zeikus	1987	27
20	Conversion of indene to cis -(1 S ),(2 R )-indandiol by mutants of Pseudomonas putida F1 Journal of Industrial Microbiology & Biotechnology ·Neal Connors, R Prevoznak, Michel Chartrain, J. Reddy, Rahul Singhvi, Z Patel, R. Olewinski, Peter Salmon, Jayne Louise Wilson, R. Greasham	1997	26

About Michel Chartrain

Michel Chartrain is a scholar working on Molecular Biology, Biomedical Engineering, Organic Chemistry, Pharmacology and Pharmacology, having authored 64 papers that have together received 1.8k indexed citations. Recurring topics across this work include Enzyme Catalysis and Immobilization (29 papers), Microbial Metabolic Engineering and Bioproduction (25 papers), Steroid Chemistry and Biochemistry (15 papers), Viral Infectious Diseases and Gene Expression in Insects (10 papers), Innovative Microfluidic and Catalytic Techniques Innovation (8 papers), Pharmacogenetics and Drug Metabolism (7 papers), Biofuel production and bioconversion (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Biotechnology (162 citations), Molecular Biology (1.3k citations), Pharmacology (116 citations), Building and Construction (174 citations) and Pollution (118 citations). Michel Chartrain has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include J. G. Zeikus, Barry C. Buckland, Randolph Greasham, David K. Robinson, Kristala Jones Prather, Jason C. Murphy, Sangeetha L. Sagar, Jürgen Thiele, R. Greasham and C. F. Hirsch. Their work appears in journals such as Journal of Industrial Microbiology & Biotechnology, Enzyme and Microbial Technology, Applied and Environmental Microbiology, Journal of Molecular Catalysis B Enzymatic and Biotechnology Progress.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact